Lymphocyte Signaling

Thioredoxin 1 Blocking Peptide

イイネ!(0) Thioredoxin 1 Blocking Peptide Data Sheet PDF
CSTコード 包装
希望納入価格 (円)
国内在庫 i
2012年2月9日15時20分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#1057S100 μg16,000
ログインすると国内在庫状況がご確認いただけます。

Thioredoxin抗体製品一覧

用途
免疫組織染色
貯法
-20℃
使用目的
Thioredoxin 1 (C63C6) Rabbit mAb (#2429) の反応をブロックし、抗体の反応特異性を確認するために使用
社内データ

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded breast carcinoma tissue using Thioredoxin 1 (C63C6) Rabbit mAb #2429 in the presence of control peptide (left) or Thioredoxin 1 Blocking Peptide (right).

バックグラウンド

Thioredoxin is a small redox protein found in many eukaryotes and prokaryotes. A pair of cysteines within a highly conserved, active site sequence can be oxidized to form a disulfide bond which is then reduced by thioredoxin reductase (1). Multiple forms of thioredoxin have been identified, including cytosolic thioredoxin 1 (Trx1) and mitochondrial thioredoxin 2 (Trx2). Thioredoxin participates in many cellular processes including redox signaling, response to oxidative stress and protein reduction (1). A potential role of thioredoxin in human disorders such as cancer, aging and heart disease is currently under investigation (2). Thioredoxin can play a key role in cancer progression, as it acts as a negative regulator of the proapoptotic kinase ASK1 (3) Changes in thioredoxin expression have been associated with meningococcal septic shock and acute lung injury (4,5).

  1. Watson, W.H. et al. (2004) Toxicol. Sci. 78, 3-14.
  2. Burke-Gaffney, A. et al. (2005) Trends Pharmacol. Sci. 26, 398-404.
  3. Saitoh, M. et al. (1998) EMBO J. 17, 2596-2606.
  4. Callister, M.E. et al. (2007) Intensive Care Med. 33, 364-367.
  5. Callister, M.E. et al. (2006) Thorax 61, 521-527.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2429   Thioredoxin 1 (C63C6) Rabbit mAb

本製品は試験研究用です。

Thioredoxin 1 Blocking Peptide

Product Pathways

Tools

Applications